Digital Management of Sleep Health
1 other identifier
interventional
358
1 country
1
Brief Summary
The goal of this clinical trial is to explore whether cognitive behavioral intervention for insomnia(CBT-I) realized through audio, video, and articles on smartphone apps("ForSleep" developed by the investigators) can improve the sleep quality of insomnia patients. The main question it aims to answer is: Does CBT-I delivered via smartphone apps improve sleep quality evaluated by scales in patients with insomnia? Investigators will compare the treatment group receiving the CBT-I intervention via smartphone apps to a control group receiving relaxation training to see if there are significant improvements in sleep quality. Participants will be asked to: Use an app("ForSleep") designed for CBT-I to follow a structured therapy program. Complete daily sleep diaries and periodic scales to track their sleep quality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 20, 2024
CompletedFirst Posted
Study publicly available on registry
July 1, 2024
CompletedJune 4, 2025
May 1, 2025
4 months
June 20, 2024
May 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pittsburgh Sleep Quality Index Scale(PSQI)
A scale that evaluates sleep quality, the scale scores range from 0 to 21, and lower scores mean a better outcome
baseline(before the intervention); intervention stage(every week during 3-week intervention); follow-up stage(every week during 2-week follow-up)
Secondary Outcomes (4)
Dysfunctional Beliefs and Attitudes about Sleep Scale(DBAS)
baseline(before the intervention); intervention stage(every week during 3-week intervention); follow-up stage(every week during 2-week follow-up)
Sleep Hygiene Index Scale(SHI)
baseline(before the intervention); intervention stage(every week during 3-week intervention); follow-up stage(every week during 2-week follow-up)
The Insomnia Severity Index Scale(ISI)
baseline(before the intervention); intervention stage(every week during 3-week intervention); follow-up stage(every week during 2-week follow-up)
Epworth Sleepiness Scale(ESS)
baseline(before the intervention); intervention stage(every week during 3-week intervention); follow-up stage(every week during 2-week follow-up)
Study Arms (2)
Intervention Group
EXPERIMENTALParticipants receive digital cognitive behavioral intervention for insomnia(dCBT-I) via their smartphone, and can freely access relaxing music in the app
Control Group
OTHERParticipants can only freely access relaxing music in the app. They don't have access to dCBT-I
Interventions
A digital cognitive behavioral intervention course that addresses multiple aspects such as basic sleep knowledge, sleep hygiene, sleep behaviors, improving negative cognition, and improving emotions. The intervention is delivered through video, audio, and text formats.
Participants can freely listen relaxing music
Eligibility Criteria
You may qualify if:
- Age 18-65 years old
- Insomnia Severity Index Scale (ISI) score of 8\~21
- Proficient in the use of smartphones
- Chinese native speaker
You may not qualify if:
- Those with other combined sleep problems, such as apnoea syndrome, restless leg syndrome, etc.
- Women during pregnancy
- risky jobs that require high concentration, such as working at heights, long-distance driving, etc.
- previous or current diagnosis of severe neurological disorders such as epilepsy
- previous or current diagnosis of mental illness such as depression, bipolar disorder, schizophrenia, obsessive-compulsive disorder, etc.
- history of drug or alcohol abuse
- a significant negative risk of suicide
- serious physical illness (e.g., cardiovascular, hepatic, renal, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jia Xiulead
Study Sites (1)
Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University
Shanghai, Shanghai Municipality, 200433, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Shouyan Wang, PhD
Fudan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 20, 2024
First Posted
July 1, 2024
Study Start
May 1, 2023
Primary Completion
September 1, 2023
Study Completion
September 1, 2023
Last Updated
June 4, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
Due to concerns regarding patient confidentiality and privacy, the investigators are unable to share the data from our study. The sensitive nature of the data includes personal health information that could potentially identify individual participants. Despite our best efforts to anonymize the data, the risk of re-identification remains. Additionally, the investigators are bound by ethical guidelines and institutional policies that require us to protect the privacy of our participants and maintain the confidentiality of their information. As such, the investigators must restrict access to the data to ensure compliance with these ethical and legal standards.